|
Top 50 Biotechnology Companies & Their Pipelines for 2006Published by: PharmaLive Published: Dec. 1, 2006 - 79 Pages Table of Contents
AbstractIn this special report, PharmaLive editors present the drugs in development for the world’s top 50 biotechnology companies as determined by the companies’ research and development expenses in 2005. All phases of development have been considered for this special report — preclinical development, Phase I, Phase II, Phase III, and awaiting approval. The lists in this special report provide the following for each product: chemical or substance composition, intended indication, clinical status, region of development (U.S., unless otherwise noted), and the developer/marketer. In addition to the biotechnology pipelines, PharmaLive’s editors rank the top biotechnology companies based upon their 2005 research and development expenses.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||